FinTrust Capital Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

FinTrust Capital Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-105	Closed	-$23K	–	1236
2021 Q1	$23K	Hold	105	–	–	0.01%	686
2020 Q4	$12K	Sell	105 -60	-36%	-$6.72K	﹤0.01%	811
2020 Q3	$16	Hold	165	–	–	﹤0.01%	706
2020 Q2	$20K	Hold	165	–	–	0.01%	628
2020 Q1	$14K	Sell	165 -25	-13%	-$2.65K	0.01%	708
2019 Q4	$20K	Sell	190 -140	-42%	-$15.7K	0.01%	640
2019 Q3	$38K	Hold	330	–	–	0.01%	507
2019 Q2	$57K	Hold	330	–	–	0.02%	385
2019 Q1	$56K	Buy	330 +140	+74%	+$20.8K	0.02%	372
2018 Q4	$19K	Buy	+190	New	+$24.9K	0.01%	619

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

FinTrust Capital Advisors's GWPH Position: Q2 2021 in Review

FinTrust Capital Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 105 shares — an estimated $23K sold.

FinTrust Capital Advisors first reported a position in GWPH in Q4 2018 and held it in 10 quarters. The position peaked at $57K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

FinTrust Capital Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
FinTrust Capital Advisors sold 105 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $23K.
FinTrust Capital Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
FinTrust Capital Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $57K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on FinTrust Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.